FRESENIUS MEDICAL CARE-ADR (FMS) Stock Fundamental Analysis

NYSE:FMS • US3580291066

22.65 USD
-0.01 (-0.04%)
At close: Feb 25, 2026
22.65 USD
0 (0%)
After Hours: 2/25/2026, 4:15:00 PM
Fundamental Rating

4

Overall FMS gets a fundamental rating of 4 out of 10. We evaluated FMS against 101 industry peers in the Health Care Providers & Services industry. FMS has a medium profitability rating, but doesn't score so well on its financial health evaluation. FMS has a bad growth rate and is valued cheaply.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year FMS was profitable.
  • FMS had a positive operating cash flow in the past year.
  • Of the past 5 years FMS 4 years were profitable.
  • Of the past 5 years FMS 4 years had a positive operating cash flow.
FMS Yearly Net Income VS EBIT VS OCF VS FCFFMS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

1.2 Ratios

  • With a Return On Assets value of 2.33%, FMS perfoms like the industry average, outperforming 58.42% of the companies in the same industry.
  • FMS has a Return On Equity (5.55%) which is in line with its industry peers.
  • FMS has a Return On Invested Capital (3.95%) which is comparable to the rest of the industry.
  • FMS had an Average Return On Invested Capital over the past 3 years of 3.14%. This is significantly below the industry average of 8.93%.
  • The 3 year average ROIC (3.14%) for FMS is below the current ROIC(3.95%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.33%
ROE 5.55%
ROIC 3.95%
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
FMS Yearly ROA, ROE, ROICFMS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • The Profit Margin of FMS (3.66%) is better than 73.27% of its industry peers.
  • In the last couple of years the Profit Margin of FMS has declined.
  • FMS has a Operating Margin of 7.19%. This is in the better half of the industry: FMS outperforms 72.28% of its industry peers.
  • FMS's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 25.00%, FMS is in line with its industry, outperforming 52.48% of the companies in the same industry.
  • In the last couple of years the Gross Margin of FMS has declined.
Industry RankSector Rank
OM 7.19%
PM (TTM) 3.66%
GM 25%
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
FMS Yearly Profit, Operating, Gross MarginsFMS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

3

2. Health

2.1 Basic Checks

  • FMS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • FMS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
FMS Yearly Shares OutstandingFMS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
FMS Yearly Total Debt VS Total AssetsFMS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

  • FMS has an Altman-Z score of 1.78. This is a bad value and indicates that FMS is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of FMS (1.78) is comparable to the rest of the industry.
  • The Debt to FCF ratio of FMS is 5.97, which is a neutral value as it means it would take FMS, 5.97 years of fcf income to pay off all of its debts.
  • FMS's Debt to FCF ratio of 5.97 is in line compared to the rest of the industry. FMS outperforms 59.41% of its industry peers.
  • FMS has a Debt/Equity ratio of 0.73. This is a neutral value indicating FMS is somewhat dependend on debt financing.
  • FMS's Debt to Equity ratio of 0.73 is in line compared to the rest of the industry. FMS outperforms 51.49% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF 5.97
Altman-Z 1.78
ROIC/WACC0.78
WACC5.07%
FMS Yearly LT Debt VS Equity VS FCFFMS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

2.3 Liquidity

  • FMS has a Current Ratio of 1.36. This is a normal value and indicates that FMS is financially healthy and should not expect problems in meeting its short term obligations.
  • FMS's Current ratio of 1.36 is in line compared to the rest of the industry. FMS outperforms 51.49% of its industry peers.
  • A Quick Ratio of 1.00 indicates that FMS may have some problems paying its short term obligations.
  • FMS has a Quick ratio of 1.00. This is in the lower half of the industry: FMS underperforms 63.37% of its industry peers.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 1
FMS Yearly Current Assets VS Current LiabilitesFMS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

3

3. Growth

3.1 Past

  • FMS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.36%, which is quite good.
  • Measured over the past years, FMS shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.15% on average per year.
EPS 1Y (TTM)9.36%
EPS 3Y4.66%
EPS 5Y-5.15%
EPS Q2Q%-22.61%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-1.52%

3.2 Future

  • Based on estimates for the next years, FMS will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.40% on average per year.
  • Based on estimates for the next years, FMS will show a small growth in Revenue. The Revenue will grow by 3.79% on average per year.
EPS Next Y16.67%
EPS Next 2Y15.11%
EPS Next 3Y16.28%
EPS Next 5Y12.4%
Revenue Next Year2.15%
Revenue Next 2Y3.14%
Revenue Next 3Y4.72%
Revenue Next 5Y3.79%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
FMS Yearly Revenue VS EstimatesFMS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B 25B
FMS Yearly EPS VS EstimatesFMS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1 2 3

8

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 10.89, which indicates a very decent valuation of FMS.
  • Compared to the rest of the industry, the Price/Earnings ratio of FMS indicates a rather cheap valuation: FMS is cheaper than 89.11% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.98. FMS is valued rather cheaply when compared to this.
  • A Price/Forward Earnings ratio of 9.32 indicates a reasonable valuation of FMS.
  • Based on the Price/Forward Earnings ratio, FMS is valued cheaply inside the industry as 91.09% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of FMS to the average of the S&P500 Index (28.01), we can say FMS is valued rather cheaply.
Industry RankSector Rank
PE 10.89
Fwd PE 9.32
FMS Price Earnings VS Forward Price EarningsFMS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • FMS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. FMS is cheaper than 88.12% of the companies in the same industry.
  • FMS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. FMS is cheaper than 91.09% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.43
EV/EBITDA 6.41
FMS Per share dataFMS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • FMS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as FMS's earnings are expected to grow with 16.28% in the coming years.
PEG (NY)0.65
PEG (5Y)N/A
EPS Next 2Y15.11%
EPS Next 3Y16.28%

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 3.76%, FMS has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 0.49, FMS pays a better dividend. On top of this FMS pays more dividend than 98.02% of the companies listed in the same industry.
  • FMS's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 3.76%

5.2 History

  • The dividend of FMS has a limited annual growth rate of 0.31%.
  • FMS has paid a dividend for at least 10 years, which is a reliable track record.
  • FMS has decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.31%
Div Incr Years2
Div Non Decr Years2
FMS Yearly Dividends per shareFMS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

  • 58.83% of the earnings are spent on dividend by FMS. This is a bit on the high side, but may be sustainable.
  • The dividend of FMS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP58.83%
EPS Next 2Y15.11%
EPS Next 3Y16.28%
FMS Yearly Income VS Free CF VS DividendFMS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
FMS Dividend Payout.FMS Dividend Payout, showing the Payout Ratio.FMS Dividend Payout.PayoutRetained Earnings

FRESENIUS MEDICAL CARE-ADR

NYSE:FMS (2/25/2026, 4:15:00 PM)

After market: 22.65 0 (0%)

22.65

-0.01 (-0.04%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-24
Earnings (Next)05-05
Inst Owners43.91%
Inst Owner Change6.19%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap13.29B
Revenue(TTM)N/A
Net Income(TTM)718.19M
Analysts65.93
Price Target27.2 (20.09%)
Short Float %0.57%
Short Ratio3.89
Dividend
Industry RankSector Rank
Dividend Yield 3.76%
Yearly Dividend0.7
Dividend Growth(5Y)0.31%
DP58.83%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.52%
Min EPS beat(2)14.16%
Max EPS beat(2)14.89%
EPS beat(4)4
Avg EPS beat(4)17.81%
Min EPS beat(4)14.16%
Max EPS beat(4)27.17%
EPS beat(8)7
Avg EPS beat(8)16.37%
EPS beat(12)10
Avg EPS beat(12)13.79%
EPS beat(16)12
Avg EPS beat(16)10.84%
Revenue beat(2)0
Avg Revenue beat(2)-2.52%
Min Revenue beat(2)-3.33%
Max Revenue beat(2)-1.71%
Revenue beat(4)2
Avg Revenue beat(4)0.94%
Min Revenue beat(4)-3.33%
Max Revenue beat(4)6.05%
Revenue beat(8)3
Avg Revenue beat(8)-0.62%
Revenue beat(12)4
Avg Revenue beat(12)-0.64%
Revenue beat(16)6
Avg Revenue beat(16)-0.51%
PT rev (1m)-2.62%
PT rev (3m)-3.01%
EPS NQ rev (1m)12.25%
EPS NQ rev (3m)14.04%
EPS NY rev (1m)0%
EPS NY rev (3m)2.37%
Revenue NQ rev (1m)0.31%
Revenue NQ rev (3m)0.62%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)0.39%
Valuation
Industry RankSector Rank
PE 10.89
Fwd PE 9.32
P/S 0.57
P/FCF 6.43
P/OCF 4.49
P/B 0.87
P/tB N/A
EV/EBITDA 6.41
EPS(TTM)2.08
EY9.18%
EPS(NY)2.43
Fwd EY10.73%
FCF(TTM)3.52
FCFY15.55%
OCF(TTM)5.04
OCFY22.25%
SpS39.42
BVpS25.99
TBVpS-3.79
PEG (NY)0.65
PEG (5Y)N/A
Graham Number34.87
Profitability
Industry RankSector Rank
ROA 2.33%
ROE 5.55%
ROCE 5.62%
ROIC 3.95%
ROICexc 4.26%
ROICexgc 11.65%
OM 7.19%
PM (TTM) 3.66%
GM 25%
FCFM 8.93%
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
ROICexc(3y)3.31%
ROICexc(5y)4.22%
ROICexgc(3y)8.52%
ROICexgc(5y)10.56%
ROCE(3y)4.51%
ROCE(5y)5.77%
ROICexgc growth 3Y-7.67%
ROICexgc growth 5Y-10.05%
ROICexc growth 3Y-10.35%
ROICexc growth 5Y-11.48%
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
F-Score5
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF 5.97
Debt/EBITDA 3.12
Cap/Depr 47.15%
Cap/Sales 3.85%
Interest Coverage 3.87
Cash Conversion 83.24%
Profit Quality 244.33%
Current Ratio 1.36
Quick Ratio 1
Altman-Z 1.78
F-Score5
WACC5.07%
ROIC/WACC0.78
Cap/Depr(3y)41.32%
Cap/Depr(5y)47.87%
Cap/Sales(3y)3.79%
Cap/Sales(5y)4.49%
Profit Quality(3y)300.36%
Profit Quality(5y)267.36%
High Growth Momentum
Growth
EPS 1Y (TTM)9.36%
EPS 3Y4.66%
EPS 5Y-5.15%
EPS Q2Q%-22.61%
EPS Next Y16.67%
EPS Next 2Y15.11%
EPS Next 3Y16.28%
EPS Next 5Y12.4%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-1.52%
Revenue Next Year2.15%
Revenue Next 2Y3.14%
Revenue Next 3Y4.72%
Revenue Next 5Y3.79%
EBIT growth 1Y-3.43%
EBIT growth 3Y-10.72%
EBIT growth 5Y-11.17%
EBIT Next Year96.05%
EBIT Next 3Y28.86%
EBIT Next 5Y18.07%
FCF growth 1Y-5.89%
FCF growth 3Y1.25%
FCF growth 5Y3.45%
OCF growth 1Y0.06%
OCF growth 3Y-1.4%
OCF growth 5Y-1.45%

FRESENIUS MEDICAL CARE-ADR / FMS FAQ

What is the fundamental rating for FMS stock?

ChartMill assigns a fundamental rating of 4 / 10 to FMS.


Can you provide the valuation status for FRESENIUS MEDICAL CARE-ADR?

ChartMill assigns a valuation rating of 8 / 10 to FRESENIUS MEDICAL CARE-ADR (FMS). This can be considered as Undervalued.


What is the profitability of FMS stock?

FRESENIUS MEDICAL CARE-ADR (FMS) has a profitability rating of 4 / 10.


What is the expected EPS growth for FRESENIUS MEDICAL CARE-ADR (FMS) stock?

The Earnings per Share (EPS) of FRESENIUS MEDICAL CARE-ADR (FMS) is expected to grow by 16.67% in the next year.


Is the dividend of FRESENIUS MEDICAL CARE-ADR sustainable?

The dividend rating of FRESENIUS MEDICAL CARE-ADR (FMS) is 6 / 10 and the dividend payout ratio is 58.83%.